Clinical Trial Update: NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating NBS10 (AMR-001) versus placebo in patients after ST-segment elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• NBS10 (AMR-001)

Snippet

Sponsor: Lisata Therapeutics, Inc. | Conditions: ST Segment Elevation Myocardial Infarction | Phase 2 | Status: COMPLETED